期刊文献+

癌痛患者芬太尼透皮贴剂处方剂量影响因素的研究 被引量:2

Study on factors affecting prescription dose of Fentanyi Transdermai Patch for treatment on caner-pain patients
原文传递
导出
摘要 目的了解癌痛患者使用芬太尼透皮贴剂处方剂量的影响因素,为居家宁养护理中正确给予镇痛治疗提供依据。方法对居家宁养的100例中、重度疼痛的癌症患者使用芬太尼透皮贴剂镇痛,以患者不感觉疼痛为准,观察疼痛程度、疼痛部位、性别、年龄与用药剂量的关系。结果重度疼痛患者的维持剂量高于中度疼痛患者,而不同疼痛部位、性别、年龄患者的维持剂量差异无统计学意义。结论疼痛程度是唯一影响芬太尼透皮贴剂处方剂量的因素,实施镇痛治疗时应首先加以考虑。 Objective To analyze the factors affecting prescription dose of Fentanyl Transdermal Patch for treatment on caner-pain patients, and to provide a basis for correctly giving ease pain treatment in peaceful recuperation and nursing. Methods For 100 cases with moderate or severe cancer pain who stayed in home for a peaceful recuperation, fentanyl transdermal patch was used to ease their pains. The relationship betweem pain degree, pain region, sex and age, and the administration dose was observed, taking the patients not feeling pain as the standard. Results The maintaining dose for patients with severe cancer pain was higher than that for patients with moderate cancer pain. But, there was no statistical meaning for the differences on maintaining doses in terms of pain region, sex and age. Conclusions Pain degree is the unique factor affecting close of fentanyl transdermal patch, and should be firstly considered when applying treatment of easing pain.
出处 《中华现代护理杂志》 2009年第25期2481-2483,共3页 Chinese Journal of Modern Nursing
基金 李嘉诚基金会全国宁养医疗服务计划赞助课题
关键词 芬太尼 疼痛 因果律 护理 Fentanyl Pain Causality Nursing
  • 相关文献

参考文献5

二级参考文献16

  • 1徐国柱,蔡志基.镇痛药临床评价方法研究[J].中国新药杂志,1995,4(4):20-22. 被引量:256
  • 2World Health Organization.Cancer Pain Relief:with a Guide to Opioid Availability[M].2nd Ed.Geneva:World Health Organization,1996.
  • 3Portenoy RK,Southam MA,Gupta SK,et al.Transdermal fentanyl for cancer pain-repeated dose pharmacokinetics[J].Anesthesiology,1993,78(1):36~43
  • 4Thompson JP,Bower AM,Liddle AM,et al.Perioperative pharmacokinetics of transdermal fentanyl in elderly and young adult patients[J].BrJ Anaesth,1998,81 (2):152~154
  • 5Ahmedzai S,Brooks D.Transdermal fentanyl versus sustainedrelease oral morphine in cancer pain:preference,efficiency,and quality of life.The TTS-Fentanyl Comparative Trial Group[J].J Pain Symptom Manage,1997,13(5):254~261
  • 6Radbruch L,Sabatowski R,Petzke F.Transdermal fentanyl for the management of cancer pain:a survey of 1005 patients[J].Palliat Med,2001,15(4):309~321
  • 7Radbruch L,Elsner F.Glinical experience with transdermal fentanyl for the treatment of cancer pain in Germany[J].Keio J Med,2004,53(1):23~29
  • 8Donner B,Zenz M,Tryba M.Direct conver from oral morphine to transddermal fenwnal:a multicenter study in patient with cancer pain[J].Pain,1996,64(3):527~534
  • 9李同度.癌症疼痛抗制与姑息治疗分册[M].北京:北京医科大学中国协和医科大学出版社,1999:18.
  • 10Benedetti C, Brock C, Cleeland C, et al. NCCN practice guidelines for cancer pain [J].Oncology (Willidton Park), 2000, 14 (11A) :135.

共引文献91

同被引文献17

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部